ATPase activity measurements were performed while described in the techniques in the current presence of sorafenib, pazopanib or regorafenib (assays in triplicate +/?SEM, performed 3 x, one research is shown)

ATPase activity measurements were performed while described in the techniques in the current presence of sorafenib, pazopanib or regorafenib (assays in triplicate +/?SEM, performed 3 x, one research is shown). + sildenafil] lethality. Identical data compared to that with afatinib